CTI BioPharma Corp. (CTIC)

Jun 26, 2023 - CTIC was delisted (reason: acquired by Sobi)

9.09

0.00 (0.00%)

Inactive · Last trade price on Jun 23, 2023

CTI BioPharma Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Revenue	75.77	53.95	0	0	3.35	26.29
Revenue Growth	3201.48%	-	-	-	-87.28%	4.55%
Gross Profit	71.31	50.43	0	0	3.35	26.29
Operating Income	-53.93	-79.8	-95.33	-47.77	-40.71	-32.9
Net Income	-69.24	-92.99	-97.91	-52.45	-40.02	-29.4
Earnings Per Share	-0.56	-0.81	-1.09	-0.74	-0.69	-0.52
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Investments	59.01	79.94	65.45	52.45	33.67	67.04
Total Debt	116.46	109.08	47.38	4.46	9.27	14.08
Net Cash (Debt)	-57.44	-29.14	18.07	48	24.4	52.96
Net Cash Growth	-	-	-62.36%	96.71%	-53.93%	81.37%
Net Cash Per Share	-0.44	-0.25	0.20	0.67	0.42	0.94

Cash Flow & CapEx

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Operating Cash Flow	-82.32	-81.19	-84.89	-42.21	-27.82	-39.82
Capital Expenditures	0	0	0	-0.02	0	-0.03
Free Cash Flow	-82.32	-81.19	-84.89	-42.22	-27.82	-39.86
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Gross Margin	94.11%	93.49%	-	-	100.00%	100.00%
Operating Margin	-71.18%	-147.91%	-	-	-1217.07%	-125.14%
Pretax Margin	-91.38%	-172.37%	-	-	-1196.41%	-111.53%
Profit Margin	-91.38%	-172.37%	-	-	-1196.41%	-111.83%
FCF Margin	-108.64%	-150.50%	-	-	-831.75%	-151.61%

Valuation

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Oct '26 Oct 25, 2026	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
PS Ratio	15.82	14.14	-	-	27.39	1.62